BioLineRx BLRX
NASDAQ BLRX
$2.04 -0.07 (-3.32%)
As of: Oct 22, 2026 · 2:13 PM EDT

BioLineRx (BLRX) Change in Other Operating Liabilities (2024)

Updated

Analysis

BioLineRx (BLRX) Change in Other Operating Liabilities (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,171.69 Bn 1,140.28 Bn 19.71 Bn -
2 Johnson & Johnson 649.22 Bn 569.08 Bn 17.30 Bn 2.69 Bn
3 AbbVie 504.17 Bn 477.29 Bn 12.70 Bn -
4 Merck 366.35 Bn 320.73 Bn 12.21 Bn -
5 Novartis Ag 303.54 Bn 267.53 Bn 11.24 Bn -
6 Astrazeneca 269.49 Bn 243.18 Bn 12.86 Bn -
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 195.09 Bn 169.29 Bn 6.22 Bn -
9 Pfizer 172.48 Bn 119.12 Bn 10.94 Bn -112.00 Mn
10 BioLineRx 8.38 Mn -68.14 Mn 235,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.26 Mn
Sep 30, 2024 -3.22 Mn
Jun 30, 2024 -3.55 Mn
Mar 31, 2024 -3.93 Mn
API Access

BioLineRx Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=BLRX&period=max&api_key=YOUR_API_KEY